Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.66 and traded as low as $1.91. Aemetis shares last traded at $1.94, with a volume of 566,085 shares.
Analysts Set New Price Targets
Several research analysts have recently issued reports on AMTX shares. StockNews.com raised Aemetis to a "sell" rating in a research report on Wednesday, February 5th. Ascendiant Capital Markets increased their price objective on Aemetis from $18.00 to $19.00 and gave the stock a "buy" rating in a report on Monday, March 17th. Finally, HC Wainwright restated a "buy" rating and set a $28.00 target price on shares of Aemetis in a report on Friday, March 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $14.56.
Read Our Latest Research Report on AMTX
Aemetis Trading Down 6.1 %
The company has a market cap of $98.11 million, a PE ratio of -0.81 and a beta of 1.48. The firm has a 50 day moving average of $2.01 and a two-hundred day moving average of $2.65.
Institutional Trading of Aemetis
Several institutional investors have recently bought and sold shares of AMTX. ProShare Advisors LLC purchased a new position in Aemetis in the fourth quarter worth about $27,000. Tower Research Capital LLC TRC raised its holdings in Aemetis by 128.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company's stock worth $28,000 after acquiring an additional 5,859 shares during the last quarter. Voya Investment Management LLC bought a new position in Aemetis in the 4th quarter valued at approximately $28,000. Clear Harbor Asset Management LLC purchased a new stake in Aemetis during the 4th quarter valued at $44,000. Finally, Intech Investment Management LLC bought a new stake in shares of Aemetis in the 4th quarter worth $46,000. 27.02% of the stock is owned by hedge funds and other institutional investors.
Aemetis Company Profile
(
Get Free Report)
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Read More
Before you consider Aemetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.
While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.